Locations:

Research

May 23, 2017/Cancer/Research

A New Strategy for Cancer Treatments

Moving from whack-a-mole to chess

May 8, 2017/Cancer/Research

Promising New Combination Therapy for Advanced, HER2+ Breast Cancer Shown Safe and Effective

Neratinib and trastuzumab emtansine (T-DM1) combination potent and well tolerated

March 15, 2017/Cancer/Research

Cleveland Clinic Researcher Receives $5.5 Million Outstanding Investigator Award

Maciejewski honored for work in bone marrow failure syndromes

February 27, 2017/Cancer/Research

Multigene Panel Testing Reveals Mutations in Early Onset CRC Patients

Results suggest: Offer broad testing to all of them

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

February 6, 2017/Cancer/Research

Promise of PARP Inhibitors for BRCA1/BRCA2 Cancers

Clinical trials testing olaparib in breast cancer

January 16, 2017/Cancer/Research

Researchers Discover How Glioblastoma Stem Cells Evade the Immune System

Finding has potential to improve treatment

September 12, 2016/Cancer/Research

Study Shows Active Surveillance is Safe and Viable in Some Metastatic Renal Cell Carcinoma Patients

Survival for months or several years while delaying treatment is possible

June 22, 2015/Cancer/Research

A Potential New Treatment for Aggressive Lymphomas

More efficient, safer therapy may be on horizon

January 7, 2015/Cancer/Research

Next Generation Sequencing Drives New Insights on Cancers

New information poised to individualize patient care

Mouse-tumors-control-(left)-and-VEGF-Ax-690-x-380

October 15, 2014/Cancer/Research

Can a VEGF-A Variant Help Halt the Spread of Cancer?

A new discovery may help slow the growth of tumors — and change the research and treatment of cancer.

BackPage 25 of 26Next